NCT01619969View on ClinicalTrials.gov

Celgosivir as a Treatment Against Dengue

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

July 31, 2013

Conditions
Dengue Fever
Interventions
DRUG

celgosivir

100 mg capsules, 400 mg loading dose 200 mg bid

DRUG

placebo

Capsules of identical appearance containing starch

Trial Locations (1)

169608

Singapore General Hospital, Singapore

All Listed Sponsors
collaborator

Duke-NUS Graduate Medical School

OTHER

lead

Singapore General Hospital

OTHER

NCT01619969 - Celgosivir as a Treatment Against Dengue | Biotech Hunter | Biotech Hunter